Aurora Spine received FDA 510(k) clearance for the AERO Facet Fusion System. Initial surgeries are slated for late 3Q25.
The system is a novel, patent-pending device designed to provide a minimally invasive solution for facet joint-related pain or instability. Cleared for use from spinal levels C2 to S1 (inclusive), the system can be used as a stand-alone facet fusion procedure or as an adjunct to larger spinal fusion surgeries.
Engineered for earlier use in the continuum of care, AERO is suitable for patients experiencing mechanical back pain, minor instability or degenerative joint disease who have not responded to conservative therapies. The system incorporates intuitive instrumentation and implant technology designed to promote bone fusion while minimizing soft tissue disruption.
Aurora Spine received FDA 510(k) clearance for the AERO Facet Fusion System. Initial surgeries are slated for late 3Q25.
The system is a novel, patent-pending device designed to provide a minimally invasive solution for facet joint-related pain or instability. Cleared for use from spinal levels C2 to S1 (inclusive), the system can be used as a...
Aurora Spine received FDA 510(k) clearance for the AERO Facet Fusion System. Initial surgeries are slated for late 3Q25.
The system is a novel, patent-pending device designed to provide a minimally invasive solution for facet joint-related pain or instability. Cleared for use from spinal levels C2 to S1 (inclusive), the system can be used as a stand-alone facet fusion procedure or as an adjunct to larger spinal fusion surgeries.
Engineered for earlier use in the continuum of care, AERO is suitable for patients experiencing mechanical back pain, minor instability or degenerative joint disease who have not responded to conservative therapies. The system incorporates intuitive instrumentation and implant technology designed to promote bone fusion while minimizing soft tissue disruption.
Copy to clipboard 
